Markets
Indian Stock Market Analysis: Sensex & Nifty 50
Market Activity Analyzed Today’s trading session on the Indian stock market, specifically the BSE Sensex and Nifty 50, saw a slight upward trend. The Sensex....
Muthoot Microfin Capital Raise: Secured Bonds Analysis
Muthoot Microfin’s Capital Raise Analyzed Muthoot Microfin, a major player in gold loan services, is taking a significant step to strengthen its finances. They’ve raised....
Bandhan Bank NPA Sales: Asset Reconstruction Companies Involved
Bandhan Bank’s NPA Sales Analyzed Bandhan Bank, a privately owned bank with a large customer base, is selling off some of its bad loans. They’ve....
GAIL (India) Share Price Analysis – Stock Drop
GAIL (India) Share Price Analyzed GAIL (India) shares dropped 7% on Friday, reaching ₹171.80 on the BSE. This happened because the Petroleum and Natural Gas....
India Consumer Internet Sector: Eternal Analysis
India’s Consumer Internet Sector Analyzed Key Points Elara Capital sees Eternal as a key player in India’s growth. Swiggy gets an “accumulate” rating with a....
Asian Markets Stabilize: Fed Rate Cut Hopes Rise
Asian Markets Stabilize After November Turbulence Asian stock markets finished November with a positive trend, signaling a shift after a difficult month. This recovery is....
Ashoka Buildcon Share Price Drop: NHAI Bid Suspension
Ashoka Buildcon Share Drop Analyzed Key Points Share price fell 6%, hitting ₹172.9 per share. NHAI bid suspension due to a fatal construction accident. Investigation....
Meesho IPO Analysis: Date, Price & Investment
Meesho IPO Analyzed Meesho, a popular online shopping platform, is planning to become a publicly traded company through an IPO (Initial Public Offering) on December....
Zydus Empagliflozin/Linagliptin Approval: Generic Glyxambi Approved
Zydus Lifesciences’ Empagliflozin/Linagliptin Approval Analyzed Zydus Lifesciences has achieved a significant milestone: the U.S. Food and Drug Administration (FDA) has granted tentative approval for their....
Western Conglomerate Sales Decline: Analysis of Losses
Western Conglomerate’s Sales and Profits: An Analysis Western Conglomerate recently reported some challenging financial results. Sales dropped significantly, down 33% to just Rs 9.14 crore.....
